Who may be eligible for this diabetes clinical trial?

Adults aged 18 or older with type 1 or type 2 diabetes who use insulin therapy and continuous glucose monitoring may be eligible. Participants must be able to use their glucose monitor app to mark sexual activity and agree to participate for 3 months. Please review eligibility criteria for more details.

Is there any cost to participate in this diabetes clinical trial?

Study-related care, including the study procedure and all trial visits, is provided at no cost. Personal travel and other expenses may vary and are not guaranteed to be covered. Participants should plan accordingly.

Actively Recruiting

Age: 18Years +

All Genders

ID07286500

Impact of Sexual Activity on Hypoglycemia Risk in Adults With Type 1 and Type 2 Diabetes Under Insulin Therapy and Continuous Glucose Monitoring CGM

Q: What is this study trying to find out about diabetes and sexual activity?

This study is exploring whether sexual activity affects the risk of low blood sugar (hypoglycemia) in adults with type 1 or type 2 diabetes who use insulin therapy and continuous glucose monitoring. Researchers want to better understand patient concerns and improve safety guidance. The study is led by the Medical University of Warsaw.

Led by Medical University of Warsaw · Updated on 2025-12-16

100

Participants Needed

Research Sites

1 weeks

Total Duration

AI-Summary

What this Trial Is About

This research aims to understand if sexual activity affects the risk of low blood sugar hypoglycemia in adults with type 1 or type 2 diabetes who use insulin therapy and continuous glucose monitoring CGM. Sexual health is important but often overlooked in diabetes care, and fear of hypoglycemia during or after sexual activity may reduce quality of life. The study addresses this gap using new remote monitoring technology to study glucose changes related to sexual activity. Participants will use CGM systems like LibreView or Dexcom Clarity to track glucose levels during and up to 6 hours after sexual activity, which they mark in their CGM app using a neutral symbol. The study is observational with no assigned treatments participants continue their usual insulin therapy and self-management. Each person will be observed for 3 months, comparing glucose data from sexual activity days to days without sexual activity. During the study, researchers will collect glucose data remotely and receive basic clinical information from healthcare providers. They will analyze the proportion of sexual activity episodes linked to hypoglycemia and compare frequency and mean glucose levels on days with and without sexual activity. Participants data are anonymized and securely handled. The study hopes to help reduce patient fears and guide future recommendations for safe sexual activity with insulin therapy.

CONDITIONS

Brief Title

"Sexual Activity and Hypoglycemia Risk in Adults With Type 1 or Type 2 Diabetes Using Insulin Therapy and Continuous Glucose Monitoring"

Who Can Participate

Age: 18Years +

All Genders

Eligibility Criteria

You may qualify if you...

Adults aged 618 years.
Diagnosis of type 1 or type 2 diabetes.
Current use of a continuous glucose monitoring (CGM) system.
Treatment with insulin therapy in any regimen.
Ability to operate the CGM application and mark the start of sexual activity.
Willingness to participate for 3 months.
Signed informed consent.

You will not qualify if you...

Inability to independently use the CGM application.
No sexual activity during the study period.
Withdrawal of consent at any time.
Any condition that, in the opinion of the investigator, prevents safe participation.

Research Team

Dominika Orłowska

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here